Cancer is a group of diseases in which abnormal cells divide without control, invade nearby tissues, and can spread to other parts of the body. It is not a single illness but a collection of more than 100 related conditions that share this core behavior. In 2022, an estimated 20 million new cancer cases were diagnosed worldwide, with 9.7 million deaths, making it one of the leading causes of death globally.
What Makes a Cell Cancerous
Your body contains trillions of cells that normally grow, divide, and die on a predictable schedule. Cancer begins when something disrupts that schedule. A cell acquires changes to its DNA that tell it to keep dividing when it should stop, and to ignore the signals that would normally trigger its death. Over time, these rogue cells accumulate into a mass of tissue called a tumor.
Normal cells have built-in brakes. Genes called tumor suppressors slow cell growth or tell damaged cells to self-destruct through a process called programmed cell death. Cancer cells find ways around these brakes. They may lose the genes responsible for self-destruction entirely, or they may overactivate genes that suppress the death signal. At the same time, other genes that normally help cells grow (called proto-oncogenes) can mutate into permanently “on” versions, like a gas pedal stuck to the floor. The combination of a stuck gas pedal and broken brakes is what allows cancer cells to multiply without limit.
Researchers have identified several core traits that cancer cells share. They sustain their own growth signals, dodge the body’s growth-suppressing mechanisms, resist programmed cell death, replicate indefinitely, build new blood vessels to feed themselves, and eventually invade other tissues. Cancer cells also tend to rewire the way they use energy and find ways to hide from the immune system.
Tumors: Benign vs. Malignant
Not every tumor is cancer. Benign tumors are localized growths that don’t invade surrounding tissue or spread to distant organs. They can sometimes grow large enough to cause problems by pressing on nearby structures, but they stay put. Many benign tumors never need treatment at all.
Malignant tumors are the ones classified as cancer. The critical difference is their ability to invade. Malignant cells push into neighboring tissues, enter blood vessels or lymph channels, travel to distant sites, and establish new growths there. This process, called metastasis, is what makes cancer dangerous and difficult to treat. A cancer that remains confined to its original location is far more treatable than one that has spread.
How Cancer Spreads
Metastasis follows a rough sequence. First, cancer cells invade the tissue surrounding the original tumor. Then they break into nearby blood vessels or lymph channels, a step called intravasation. Once in the bloodstream or lymph system, they circulate through the body. Most of these traveling cells die, but some exit the vessels at a distant site (extravasation) and begin colonizing new tissue. A breast cancer that spreads to the bones, for example, is still breast cancer. It carries the same cellular identity as the original tumor, just in a new location.
Major Types of Cancer
Cancers are classified by the type of tissue where they originate.
- Carcinomas start in the cells lining your organs and body surfaces, such as the skin, lungs, breast, and colon. They account for 80 to 90 percent of all cancer cases.
- Sarcomas arise in supportive and connective tissues like bone, cartilage, muscle, and fat. They are relatively rare.
- Leukemias are cancers of the bone marrow and blood. Sometimes called “liquid cancers,” they typically involve the overproduction of immature white blood cells.
- Lymphomas develop in the lymphatic system, the network of vessels and nodes that produces infection-fighting white blood cells. Unlike leukemias, lymphomas form solid tumors in lymph nodes or organs like the spleen.
- Myelomas originate in plasma cells within bone marrow. Plasma cells normally produce proteins found in your blood, and myeloma disrupts that function.
What Causes the DNA Changes
Cancer rarely has a single cause. Most cases result from an accumulation of DNA damage over a lifetime. Some of that damage comes from external factors: tobacco smoke, ultraviolet radiation, certain viruses, and chemical exposures. Some comes from internal errors, random mistakes that occur every time a cell copies its DNA during division. A small fraction of cancers are driven by inherited gene mutations passed from parent to child, giving certain families a higher baseline risk.
Genetic instability plays a central enabling role. The more unstable a cell’s DNA becomes, the faster it can acquire the mutations needed to grow unchecked. Chronic inflammation also creates a fertile environment for cancer development, because inflammatory signals can promote cell survival and division in ways that favor tumor growth.
How Cancer Is Staged
Once cancer is diagnosed, doctors determine how far it has progressed using a system called TNM staging. The T describes the size and extent of the primary tumor, on a scale from T1 (small) to T4 (large or deeply invasive). The N describes whether cancer has reached nearby lymph nodes, with higher numbers indicating more nodes involved. The M indicates whether the cancer has metastasized to distant parts of the body: M0 means it hasn’t, M1 means it has.
These three values are combined into an overall stage, typically ranging from stage I (early, localized) to stage IV (spread to distant organs). Staging matters because it shapes the treatment approach and gives a clearer picture of prognosis. A stage I cancer confined to a small area is often curable with surgery alone, while a stage IV cancer with widespread metastasis typically requires systemic treatments and carries a more guarded outlook.
Why “Cancer” Is Really Many Diseases
Two cancers that arise in the same organ can behave completely differently depending on their specific genetic mutations, growth rate, and response to the immune system. A slow-growing prostate cancer in an older adult may never cause symptoms or require treatment, while an aggressive pancreatic cancer can be life-threatening within months. This is why oncologists increasingly rely on molecular profiling, analyzing the specific genetic changes driving a tumor, to choose treatments tailored to the biology of each individual cancer rather than just its location in the body.
The unifying thread across all these diseases remains the same: cells that have escaped the body’s normal controls on growth and death, gaining the ability to invade and spread. Everything else, from the type of tissue involved to how fast it progresses, determines which specific disease a person is facing and how it will be managed.